Subscribe to the Gensco® Research Newsletter
Please complete the following form to receive updates on Gensco® Research. Fields with an asterisk are required.
Gensco® Pharma, LLC
8550 NW 33rd Street
Miami, FL 33122
Phone: 855-7GENSCO (743-6726)
Email: info@genscopharma.com
MISSION STATEMENT
Gensco® Pharma is committed to Better Science for Health.
Our resources are focused on innovative research, the development of superior quality medications and unique delivery systems. We are an evidence-based solutions company that is progressively developing products utilizing new technologies that deliver outcomes to reduce the effects caused by disease or pathology.
EVIDENCE
Latest Research Articles
An Exploratory, Single-blind Study to Evaluate Both the Onset of Anesthesia of LiDORx® in Patients Aged 18–88 Years November 9, 2017 Clinical, Research - more...
Physician Explores Gout Treatment Options May 15, 2017 Articles, Clinical, Featured - As seen in Chain Drug Review | May 15, 2017 MIAMI — Gout is an extremely painful form of inflammatory arthritis and the… more...
The Difference Between Topical and Transdermal Medications March 29, 2017 Clinical, Research - White Paper by Robert L. Wilbur, Pharm.D., CPh | Executive Director, Medical Affairs, Gensco Pharma Abstract Topical medications are widely used… more...
Advances in Treatment of Painful Wounds November 28, 2016 Articles, Clinical, Featured - by Marc Alan Brenner, DPM, The Institute for Diabetic Foot Research As seen in Podiatry Management | November 2016 Wound management… more...
Gensco’s Astero hydrogel alleviates diabetic foot ulcers November 21, 2016 Articles, Clinical - As seen in Chain Drug Review's Diabetes Care Report. Approximately 15% of people with diabetes suffer from foot ulcers, and… more...
A Review and Case Study of Astero® (Lidocaine HCl 4%), a New Prescription Hydrogel for Painful Wounds November 16, 2016 Articles, Clinical, Featured - By Marc A. Brenner, DPM | Podiatry Management, Clinical Innovations, The Diabetic Foot. Wound pain has numerous, often interlinked, causes… more...